Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 429

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Marking Axillary Lymph Nodes With Radioactive Iodine Seeds for Axillary Staging After Neoadjuvant Systemic Treatment in Breast Cancer Patients: The MARI Procedure

Open access
Donker, Mila, Straver, Marieke E., Wesseling, Jelle, Loo, Claudette E., Schot, Margaret, Drukker, Caroline A., van Tinteren, Harm, Sonke, Gabe S., Rutgers, Emiel J. Th., Vrancken Peeters, Marie-Jeanne T. F. D.·2015·Annals of Surgery

Abstract

In Brief Objective: The MARI procedure [marking the axillary lymph node with radioactive iodine (125I) seeds] is a new minimal invasive method to assess the pathological response of nodal metastases after neoadjuvant systemic treatment (NST) in patients with breast cancer. This method allows axilla-conserving surgery in patients responding well to NST. Methods: Prior to NST, proven tumor-positive axillary lymph nodes were marked with a 125I seed. This marked lymph node is the so-called MARI-node. After NST, the MARI node was selectively removed using a γ-detection probe. A complementary axillary lymph node dissection was performed in all patients to assess whether pathological response in the MARI node was indicative for the pathological response in the additional lymph nodes. Results: A tumor-positive axillary lymph node was marked with a 125I seed in 100 patients. The MARI node was successfully identified in 97 of these 100 patients (identification rate 97%). Two patients did not undergo subsequent axillary lymph node dissection, leaving 95 patients for further analysis. The MARI node contained residual tumor cells in 65 of these 95 patients. In the other 30 patients, the MARI node was free of tumor, but additional positive lymph nodes were found in 5 patients. Thus, the MARI procedure correctly identified 65 of 70 patients with residual axillary tumor activity (false negative rate 5/70 = 7%). Conclusions: This study shows that marking and selectively removing metastatic lymph nodes after neoadjuvant systemic treatment has a high identification rate and a low false negative rate. The tumor response in the marked lymph node may be used to tailor further axillary treatment after NST. The MARI procedure (marking the axillary lymph node with radioactive iodine seeds) is a new minimal invasive method to assess the pathological response of nodal metastases after neoadjuvant systemic treatment in patients with breast cancer. The tumor response in the marked lymph node may be used to tailor further axillary treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/sla.0000000000000558

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 429

Metadata

Authors
Donker, M., Straver, M. E., Wesseling, J., Loo, C. E., Schot, M., Drukker, C. A., van Tinteren, H., Sonke, G. S., Rutgers, E. J. T., & Vrancken Peeters, M.-J. T. F. D.
Venue
Annals of Surgery
Published
2015-02
Volume
261
Issue
2
Pages
378-382
ISSN
0003-4932 (ISSN-L)
OpenAlex
W2012620884
Cited by
429
References
14
FWCI
6.51
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Marking Axillary Lymph Nodes With Radioactive Iodine Seeds for Axillary Staging After Neoadjuvant Systemic Treatment in Breast Cancer Patients: The MARI Procedure. https://app.cochat.ai/papers/10.1097/sla.0000000000000558
The paper
Donker, M., Straver, M. E., Wesseling, J., Loo, C. E., Schot, M., Drukker, C. A., van Tinteren, H., Sonke, G. S., Rutgers, E. J. T., & Vrancken Peeters, M.-J. T. F. D. (2015). Marking Axillary Lymph Nodes With Radioactive Iodine Seeds for Axillary Staging After Neoadjuvant Systemic Treatment in Breast Cancer Patients: The MARI Procedure. Annals of Surgery. https://doi.org/10.1097/sla.0000000000000558

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.